A Korean research team revealed that inducing autophagy significantly enhances homologous recombination efficiency in CRISPR-Cas9 gene editing, improving target specificity for genetic disease correction. This strategy shifts repair preference from error-prone pathways to accurate homologous repair. This advancement promises to increase therapeutic precision and reduce off-target effects, heralding a new phase in genome editing technologies.